Home › Funds › 683 Capital Management, LLC › ANAB

683 Capital Management, LLC position in ANAB

ANAPTYSBIO INC COM · Health Care

683 Capital Management, LLC reported holding 660,000 shares of ANAB (ANAPTYSBIO INC COM) in its Q2 2026 13F filing — a position valued at US$44.6M, representing 2.37% of its reported portfolio and ranking #9 among its reported holdings. 683 Capital Management, LLC has disclosed ANAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)660.00K sh
Reported value held$44.55M
Portfolio Weight2.37%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 683 Capital Management, LLC's ANAB position evolved

683 Capital Management, LLC first disclosed a stake in ANAB in Q1 2025 at 195,627 shares (US$3.6M). The position peaked in Q2 2026 at 660,000 shares, worth US$44.6M. Across 6 filings, 683 Capital Management, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 660,000 shares valued at US$44.6M — an increase of 35,000 shares quarter over quarter.. Notable position changes include a 156% increase in Q2 2025 (shares rose 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 195.63K $3.64M New
Q2 2025 500.00K $11.10M Add
Q3 2025 547.00K $16.75M Add
Q4 2025 648.09K $31.42M Add
Q1 2026 625.00K $34.66M Reduce
Q2 2026 660.00K $44.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC COM) is a Health Care company. 46 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Affinity Asset Advisors, LLC (US$55.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has 683 Capital Management, LLC held ANAB?

683 Capital Management, LLC has disclosed ANAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is 683 Capital Management, LLC's current position in ANAB?

As of Q2 2026, 683 Capital Management, LLC holds 660.00K shares of ANAB (ANAPTYSBIO INC COM), valued at $44.55M, representing 2.37% of its reported portfolio and ranking #9.

Has 683 Capital Management, LLC been buying or selling ANAB?

In the latest 13F filing (Q2 2026), 683 Capital Management, LLC increased its position in ANAB. The position peaked in Q2 2026 at 660.00K shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Affinity Asset Advisors, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.